To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Addition of IV parecoxib to femoral nerve block in TKA reduces pain compared to placebo

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2015

Addition of IV parecoxib to femoral nerve block in TKA reduces pain compared to placebo

Vol: 4| Issue: 8| Number:16| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Intravenous Parecoxib and Continuous Femoral Block for Postoperative Analgesia after Total Knee Arthroplasty. A Randomized, Double- Blind, Prospective Trial

Pain Physician. 2015 May-Jun;18(3):267-76

Contributing Authors:
DG Sarridou G Chalmouki M Braoudaki A Koutsoupaki A Mela A Vadalouka

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

90 patients scheduled to undergo total knee arthroplasty (TKA) with continuous femoral nerve block were randomized to receive either intravenous parecoxib or placebo administration. Visual analog scale (VAS) pain scores were assessed at 4, 8, 12, 24, and 36 hours. Findings demonstrated significantly lower pain over 36 hours postoperatively in the parecoxib group as compared to the placebo group.

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.